Comparative Effectiveness of Psychotropic Medications for PTSD in Clinical Practice

reportActive / Technical Report | Accession Number: AD1087639 | Open PDF

Abstract:

We have completed all Year 2 tasks by the time of this report. We identified which Veterans in the final cohort received an adequate medication trial AMT of one of the five medications fluoxetine, sertraline, paroxetine, topiramate, or venlafaxine during their initial year of PTSD treatment. We then determined whether each Veteran also received pre- and post-measurement with the PTSD Checklist PCL as well as whether they met criteria for PTSD. We have developed our analytic dataset for the completion of Aims 1 and 2, and have also published or submitted three additional manuscripts supporting the methods to be used as we complete our efforts.

Author(s):
Shiner, Brian ; Cornelius, Sarah
Author Organization(s):
Veterans Education and Research White River Junction United States
Descriptive Note:
Technical Report,01 Sep 2018,31 Aug 2019
Pagination:
0079

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release;

RECORD

Collection: TR
Subject Terms
Joint Capability Areas:
JCA_5_Command and Control; JCA_5.3_Planning; JCA_4.7.2_Installation Services; JCA_4.7_Base and Installations Support; JCA_1.2.5_Lessons Learned; JCA_4_Logistics; JCA_5.5.2_Task; JCA_5.5_Direct; JCA_1.2.3_Educating; JCA_5.4_Decide; JCA_1.2.1_Training; JCA_1.3.2_Personnel Management
Modernization Areas:
AI and Machine Learning
Communities of Interest:
No COI(s) Identified
Descriptor(s):
traumatic stress disorder, Psychotropic drugs, veterans (military personnel), Data Analysis
Field(s)/Group(s):
Medicine and Medical Research, Pharmacology
Keyword(s):
ptsd (Posttraumatic stress disorder), Comparative effectiveness research, Retrospective cohort, Routine practice, amt (Adequate Medication Trials)
Report Date:
2019 Sep 01
Creation Date:
2019 Dec 18